The cost-effectiveness of blue-light therapy in the treatment of mild-to-moderate psoriasis

2017-06-01

Additional Metadata
Keywords	blue-light therapy, calcipotriol and betamethasone dipropionate gel, cost-effectiveness, Dovobet®, mild-to-moderate psoriasis
Persistent URL	doi.org/10.2217/cer-2017-0007, hdl.handle.net/1765/101095
Journal	Journal of Comparative Effectiveness Research
Note	no subscription
Organisation	Institute for Medical Technology Assessment (iMTA)
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Ansaripour, A., Thio, B., Maessen, R. (Rob)& Redekop, K. (2017). The cost-effectiveness of blue-light therapy in the treatment of mild-to-moderate psoriasis. Journal of Comparative Effectiveness Research, 6(4), 325–335.https://doi.org/10.2217/cer-2017-0007

Publication